Investing.com -- The U.S. Food and Drug Administration has introduced a new Commissioner’s National Priority Voucher (CNPV) program aimed at accelerating the drug approval process for treatments that ...

During the program’s first year, the FDA plans to issue a limited number of vouchers to companies aligned with U.S. national health priorities, which include addressing health crises, delivering ...

Investing.com -- Goldman Sachs upgraded Chinese electric vehicle makers XPeng (NYSE: XPEV) and Nio (NYSE: NIO) on improving ...

The U.S. dollar is experiencing a mild "safe haven" bid due to ongoing Iran-Israel tensions, according to a new analysis from Macquarie Group (OTC: MQBKY). The financial services ...

UBS sees a mixed macroeconomic outlook for commodities but maintains a constructive stance on the asset class over the medium ...

Chevron Corporation (NYSE: CVX) stock rose 2% following the company’s announcement of its first strategic move into the ...

Investing.com -- Bank of America cut its price target on Qualcomm Inc (NASDAQ: QCOM) to $200 from $245, citing a more ...

Concerns about Alphabet (NASDAQ:GOOGL) losing market share to ChatGPT and the rising costs of AI in search have been at the ...

Investing.com -- Baidu (NASDAQ: BIDU) is ramping up its artificial intelligence hiring efforts with its largest recruitment ...

Investing.com - Natural gas prices have surged this week as the conflict between Israel and Iran escalated, but Goldman Sachs ...

ETF momentum and institutional buying are fueling hope, even as volatility brews beneath the surface. With regulatory clarity ...

UBS reiterated a neutral view on eurozone equities, maintaining a cautious stance amid persistent near-term risks while ...